1. Carr, A. C., Shaw, G. M., Fowler, A. A. & Natarajan, R. Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock? Crit. Care 19, 418 (2015).
2. Fowler, A. A. et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J. Transl. Med. 12, 32 (2014).
3. Marik, P. E. Vitamin C for the treatment of sepsis: The scientific rationale. Pharmacol. Ther. (2018). doi:10.1016/j.pharmthera.2018.04.007
4. Zabet, M., Mohammadi, M., Ramezani, M. & Khalili, H. Effect of high-dose Ascorbic acid on vasopressor′s requirement in septic shock. J. Res. Pharm. Pract. 5, 94 (2016).
5. Kuhn, S.-O., Meissner, K., Mayes, L. M. & Bartels, K. Vitamin C in sepsis. Curr. Opin. Anaesthesiol. 31, 1 (2017).
6. Marik, P. E., Khangoora, V., Rivera, R., Hooper, M. H. & Catravas, J. Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock. Chest 151, 1229–1238 (2017).
7. Carr, A. C. & Maggini, S. Vitamin C and Immune Function. oi:10.3390/nu9111211
8. Padayatty, S. J. et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann. Intern. Med. 140, 533–7 (2004).
9. Oudemans-van Straaten, H. M., Elbers, P. W. G. & Spoelstra-de Man, A. M. E. How to Give Vitamin C a Cautious but Fair Chance in Severe Sepsis. Chest 151, 1199–1200 (2017).
10. Sartor, Z., Kesey, J. & Dissanaike, S. The Effects of Intravenous Vitamin C on Point-of-Care Glucose Monitoring. J. Burn Care Res. 36, 50–56 (2015).